Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAIClimate TechSpaceNeurotechQuantumBlockchainCybersecurity
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Section 32 was founded by Bill Maris, who previously created Google Ventures and shaped its early investment thesis. Now managing $2.3B across 5 funds including a $525M Fund 5 (2023), S32 invests at the frontiers of technology and life sciences across all stages. The portfolio of 70+ investments includes marquee exits: Coinbase (IPO), CrowdStrike (IPO), Relay Therapeutics (Nasdaq listing), Vir Bio...
Notable Investments
C
CoinbaseC
CrowdStrikeR
Relay TherapeuticsV
Vir BiotechnologyT
Thrive Earlier DetectionSimilar Funds
Ahren Innovation Capital
London, United Kingdom
DeepTech NativeBiotechRoboticsClimate TechSeedSeries A
Osage University Partners
Bala Cynwyd, United States
DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Parkwalk Advisors
London, United Kingdom
DeepTech NativeBiotechAIQuantumSeedSeries A
ARTIS Ventures
San Francisco, United States
DeepTech NativeBiotechAIMedtechSeedSeries A
M Ventures (Merck)
Amsterdam, Netherlands
DeepTech NativeBiotechSemiconductorsAdvanced MaterialsSeedSeries A
Venrock
Palo Alto, United States
GeneralistBiotechAIMedtechSeedSeries A